Manolete FY26 Revenue £28m, Forward Book £67m
Summary
Manolete Partners PLC, the UK's leading insolvency claims financing company, reported FY26 Realised Revenue of approximately £28.0m (FY25: £29.5m), reflecting strong H2 trading performance with higher value, higher margin case completions as forecast. The forward book increased significantly to £67m (FY25: £49m), representing 37% year-on-year growth driven by £32m of new cases signed in FY26 (up 23% from £26m in FY25). Gross cash receipts were £26.6m, with net debt at £11.5m. The company has approximately £4.7m net exposure to two delayed large debtor payments, and pending the audit conclusion, a bad debt provision of £1.5m-£2.0m may be recognised. The Board remains confident of increasing Realised Revenue and Realised PBT in FY27 given the forward book growth and improving insolvency market backdrop.
“The forward book at 31 March 2026 was £67m and has grown by £18m or 37% year-on-year.”
About this source
GovPing monitors London Stock Exchange for new securities & markets regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 29 changes logged to date.
What changed
Manolete Partners PLC reported full year FY26 results showing Realised Revenue of approximately £28.0m compared to £29.5m in FY25, representing a slight year-on-year decrease. However, H2 trading showed strong performance with increased higher value case completions. The forward book grew substantially to £67m, up from £49m, driven by a 23% increase in new cases signed (£32m vs £26m) and investment in the legal team and business development. Two large debtor payments remain delayed with approximately £4.7m net exposure; depending on audit conclusions, a bad debt provision of £1.5m-£2.0m may be recognised.
Investors and analysts monitoring UK-listed financial services companies should note that Manolete's 37% growth in the forward book provides revenue visibility for FY27, with large cases (over £0.5m forecast revenue) comprising £32m of the forward book. The company appointed new leadership including Mena Halton as CEO and Will Sawyer as CFO during the year, with Marcia Shekerdemian KC joining as Non-Executive Director in March 2026.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Go to News Explorer RNS Trading Statement Share this article
Full Year Trading Update
MANOLETE PARTNERS PLC Released 07:00:03 24 April 2026 RNS Number : 7350B Manolete Partners PLC 24 April 2026 24 April 2026
Manolete Partners PLC
("Manolete" or the "Company")
Full Year Trading Update
Strong H2 trading performance as forecast
Manolete, the UK's leading insolvency claims financing company, today announces a trading update for the year ended 31 March 2026 ("FY26"). All figures in this announcement remain subject to audit.
Highlights
· Strong H2 trading performance
· FY26 Realised Revenue of c.£28.0m (FY25: £29.5m) in line with expectations
· Strong gross cash receipts of £26.6m (FY25: £25.6m)
· Net Debt of £11.5m (FY25: £11.1m) and free cash outflow of £0.2m (FY25: inflow of £0.5m)
· Forward book 1 increased significantly in value to £67m (FY25: £49m) which provides confidence for increased revenue and profits in FY27
FY26 trading performance
The Company is pleased to announce that Realised Revenue for the full year is expected to be in line with expectations 2 at c.£28.0m (FY25: £29.5m). This reflects an increase in the number of higher value, higher margin case completions during the second half, as forecast.
Gross cash receipts were strong at £26.6m and represent a £1.0m increase versus the prior year. Net debt at 31 March 2026 increased to £11.5m (FY25: 11.1m) and there was a free cash outflow of £0.2m in the period (FY25: inflow of £0.5m).
The stronger trading performance in the second half enabled continued investment in new cases and helped offset one-off adjusting items 3 and the non-payment by a small number of large debtors as noted in the Company's statement of 16 September 2025. Two of these payments continue to be delayed and the Company's net exposure to these debtors is approximately £4.7m. The Board remains confident that the full amount will be received in due course. However, the Company has not yet concluded its bad debt review in conjunction with its auditors and if there is no change in circumstances before the conclusion of the audit, the Company will consider some provision against these debtors, which is likely to be in the region of £1.5m-£2.0m. The Company's expectation of Adjusted Realised Profit Before Tax (PBT) 3 is £1.9m (FY25: £0.6m) before any adjustment for these debtors.
Good progress on strategic initiatives
During the year, the Company made good progress in further strengthening its operations to provide a platform for continued growth whilst maintaining focus on its highly efficient system of working.
The Company made three new hires into the legal team to drive continued growth in the number of new case referrals and implemented new business development initiatives to support the Company's existing nationwide referral network. This has led to £32m of new cases being signed in FY26 (FY25: £26m), representing a 23% increase year-on-year, and this is expected to increase further during FY27 as the enlarged team continues to drive new case signings at higher levels of volume and value.
In relation to the Company's loan facility, HSBC has waived the requirement for former CEO Steven Cooklin to maintain a minimum shareholding in the Company.
Refreshed leadership team and Board
During the year, the Company refreshed its leadership team, with Manolete's Managing Director Mena Halton appointed as Chief Executive Officer in August 2025 and highly experienced public markets CFO Will Sawyer appointed as Chief Financial Officer in December 2025.
The Company also welcomed leading barrister Marcia Shekerdemian KC to the Board as a Non-Executive Director in March 2026. She replaced Dr. Stephen Baister, who stepped down from the Board but continues to provide consultancy to the Company.
Outlook
The forward book at 31 March 2026 was £67m and has grown by £18m or 37% year-on-year. This has been driven by the investment in the legal team and business development initiatives which has resulted in higher value cases being signed. Large cases with a forecast revenue value over £0.5m comprise £32m of the forward book, up from £21m at prior year end.
Given the growth in the forward book and the backdrop of an improving insolvency market, the Board are confident of increasing Realised Revenue and Realised PBT in FY27.
Commenting, Mena Halton, Chief Executive Officer said:
"We performed well in the second half, with an increase in the number of higher value case completions driving improved trading performance, as we forecast at the half year. At the same time, we continued to strengthen our team and new business development function to support our future growth. Our forward book has increased significantly in value and we are confident of continuing to build on our market leadership position as UK insolvencies persist at elevated levels."
The value of the forward book represents the aggregate forecast revenue on live cases excluding cartel cases.
Company compiled consensus prior to the release of this announcement for the year ended 31 March 2026: Realised Revenue £28.3m and Realised Profit Before Tax £1.5m.
3. Adjusted Realised Profit Before Tax is defined as Realised Profit Before Tax before Adjusting Items comprising reorganisation and restructuring costs and share based payment charges totalling £1.2m.
The information contained in this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement this inside information is now considered to be in the public domain.
For further information please contact:
Manolete Partners
Mena Halton (Chief Executive Officer) via Houston
Will Sawyer (Chief Financial Officer)
Canaccord (NOMAD and Sole Broker) +44 (0)20 7523 8000
Stuart Andrews
Emma Gabriel
Harry Rees
Houston (Financial PR) +44 (0)77 3303 2695
Charlie Barker +44 (0)20 4529 0549
Nick Jackman
About Manolete Partners PLC
Manolete Partners Plc is the UK's leading insolvency claims financing company. Serving a growing market worth over £500 million annually, the Company has a highly experienced team with coverage across the UK and a proven track record of generating strong historic returns across over 1,400 cases financed and completed to date.
Widely recognised as the industry leader, Manolete is the only company in the insolvency litigation funding section to be ranked in Band 1 of the legal industry's prestigious Chambers Guide five times. The Company is also five-time winner of 'Insolvency Litigation Funder of the Year' at the Turnaround, Restructuring and Insolvency Industry Awards.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END TSTUOSNRNBUSUAR London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
© 2026 London Stock Exchange plc. All rights reserved.
Related changes
Get daily alerts for London Stock Exchange
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Manolete.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when London Stock Exchange publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.